Christopher J. Sayed

2.7k citations
79 papers · 1.2k · 3 hit papers · h-index 16

Impact in

  • Dermatology top 0.2%
    • Hidradenitis Suppurativa and Treatments
    • Chemotherapy-related skin toxicity
  • Surgery top 5%
    • Colorectal and Anal Carcinomas
    • Anorectal Disease Treatments and Outcomes

Papers in

    • Hidradenitis Suppurativa and Treatments 64
    • Chemotherapy-related skin toxicity 10
    • Dermatology and Skin Diseases 2
    • Colorectal and Anal Carcinomas 35
    • Anorectal Disease Treatments and Outcomes 6

Christopher J. Sayed

65 papers receiving 1.2k citations

Christopher J. Sayed's Hit Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials 2024 · 86 citations
860+2+4Years since publication50100150200

Peers

Christopher J. Sayed
Comparison fields: 5 of 65
  • Dermatology 1.1k
  • Surgery 641
  • Epidemiology 241
  • Periodontics 12
  • Rheumatology 30
Replace J. Romaní with:
J. Romaní Spain
Seçil Vural Türkiye
Óscar Tellechea Portugal
Joel Cook United States
J.C. Moreno‐Giménez Spain
Felipe B. Cerci Brazil
Rod O’Keefe Australia
Almudena Hernández‐Núñez Spain
María Jones‐Caballero Spain
Jason C. Reutter United States
Christopher J. Sayed relative to J. Romaní Spain J. Romaní's profile →
Citations per field
00.5×9.7×
J. Romaní · 1×
Citations per year

Countries citing papers authored by Christopher J. Sayed

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Sayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Sayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Sayed more than expected).

Fields of papers citing papers by Christopher J. Sayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Sayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Sayed. The network helps show where Christopher J. Sayed may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher J. Sayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. Sayed Line = papers co-authored together Christopher J. Sayed links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Hit paper breakdown →
2019234
2
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Hit paper breakdown →
2019231
3 2021117
4
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
Hit paper breakdown →
202486
5 202061
6 202155
7 201943
8 202237
9 202335
10
Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.
201735
11 201927
12 202225
13 202118
14 202118
15 202015
16 201615
17 202113
18 202113
19 202311
20 202311

About Christopher J. Sayed

Christopher J. Sayed is a scholar working on Dermatology, Surgery, Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hidradenitis Suppurativa and Treatments (64 papers), Colorectal and Anal Carcinomas (35 papers), Chemotherapy-related skin toxicity (10 papers), Microscopic Colitis (8 papers), Anorectal Disease Treatments and Outcomes (6 papers), Autoimmune and Inflammatory Disorders (5 papers), Streptococcal Infections and Treatments (4 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Dermatology (1.1k citations), Surgery (641 citations), Epidemiology (241 citations), Periodontics (12 citations) and Rheumatology (30 citations). Christopher J. Sayed has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Iltefat Hamzavi, Gregor B. E. Jemec, Joslyn S. Kirby, Alexa B. Kimball, Alice B. Gottlieb, Afsáneh Alavi, Michelle A. Lowes, Craig N. Burkhart, Daniel B. Eisen and Robert G. Micheletti. Their work appears in journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, Pediatric Dermatology, British Journal of Dermatology and Dermatologic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact